Delivery Order SPE2DR25D2104-SPE2DR26F3SPH
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,180.52 on December 10, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of December 11, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a $1,079.01 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injections. This non-competitive, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,095.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by December 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,616.66 for Trulicity 1.5 mg/0.5 ml pen auto-injectors on December 4, 2025, with completion expected by December 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors with a ceiling value of $1,162.96 and a completion date of November 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $11,264.56 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on December 20, 2025, with completion scheduled for December 22, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a $2,997.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by April 25, 2025, with performance...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SPHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,552.03 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections on December 31, 2025, with completion targeted for January 2, 2026. This competitively awarded, non-set-aside contract operates under firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical will be delivered from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major healthcare solutions provider to federal medical procurement programs. This delivery order falls under AmerisourceBergen's substantial $999,999,999 prime IDC with DLA Troop Support Medical, valued through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The contract enables AmerisourceBergen to supply a wide range of pharmaceutical products, including diabetes medications, specialty treatments, vaccines, and medical supplies to support Department of Defense and other federal healthcare needs worldwide. The delivery order for Trulicity, a diabetes treatment, exemplifies the company's role in fulfilling critical medical supply requirements across multiple therapeutic domains for military personnel and veterans through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/30/25 |